Drug Name Normalization
Drug Name Normalization is a pharmaceutical knowledge representation task that standardizes varied textual mentions of drugs into a consistent, canonical form according to a reference terminology or ontology.
8
Publications
799
Citations
31
Authors
16
Institutions
Publications per year
2017–2026
3
Variants
Drug Entity NormalizationDrug Mention Normalization
8
1–5 of 8
31
1
h-index
United States National Library of Medicine, United States
1 publications · 18 citations
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 31
16
National Institutes of Health
Bethesda, United States
2 h-index
8 publications
2.3K citations

United States National Library of Medicine
Bethesda, United States
2 h-index
6 publications
2.3K citations
AstraZeneca (United States)
Wilmington, United States
1 h-index
1 publications
32 citations

UNSW Sydney
Sydney, Australia
1 h-index
5 publications
260 citations
Universitat de València
Valencia, Spain
1 h-index
1 publications
17 citations
AstraZeneca (Poland)
Warsaw, Poland
1 h-index
1 publications
32 citations
Département Santé Animale
Nouzilly, France
1 h-index
1 publications
32 citations
University of Konstanz
Konstanz, Germany
1 h-index
1 publications
17 citations
1–8 of 16
Repository · 2 publications · 78 citations
2
h-index
1 publications · 133 citations
1
h-index
BJCP · 1 publications · 32 citations
1
h-index
1 publications · 17 citations
1
h-index
JBMS · 1 publications · 30 citations
1
h-index
1–5